Related references
Note: Only part of the references are listed.Quantifying the impact of adherence to screening strategies on colorectal cancer incidence and mortality
Elvira D'Andrea et al.
CANCER MEDICINE (2020)
Patients' self-reported barriers to colon cancer screening in federally qualified health center settings
Meera Muthukrishnan et al.
PREVENTIVE MEDICINE REPORTS (2019)
Use of Colorectal Cancer Screening Tests by State
Djenaba A. Joseph et al.
PREVENTING CHRONIC DISEASE (2018)
Patterns and Trends in Cancer Screening in the United States
Ingrid J. Hall et al.
PREVENTING CHRONIC DISEASE (2018)
Effectiveness of a Mailed Colorectal Cancer Screening Outreach Program in Community Health Clinics The STOP CRC Cluster Randomized Clinical Trial
Gloria D. Coronado et al.
JAMA INTERNAL MEDICINE (2018)
Cancer Screening Test Use — United States, 2015
Arica White et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2017)
Colorectal Cancer Screening: Recommendations for Physicians and Patients from the US Multi-Society Task Force on Colorectal Cancer
Douglas K. Rex et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2017)
Fecal Immunochemical Test Program Performance Over 4 Rounds of Annual Screening A Retrospective Cohort Study
Christopher D. Jensen et al.
ANNALS OF INTERNAL MEDICINE (2016)
Validation of a Real-Time PCR-Based Qualitative Assay for the Detection of Methylated SEPT9 DNA in Human Plasma
Nicholas T. Potter et al.
CLINICAL CHEMISTRY (2014)
Challenges and Possible Solutions to Colorectal Cancer Screening for the Underserved
Samir Gupta et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Plasma Septin9 versus Fecal Immunochemical Testing for Colorectal Cancer Screening: A Prospective Multicenter Study
David A. Johnson et al.
PLOS ONE (2014)
Preferences for Blood-Based Colon Cancer Screening Differ by Race/Ethnicity
Jennifer M. Taber et al.
AMERICAN JOURNAL OF HEALTH BEHAVIOR (2014)
Colorectal Cancer Screening with Blood-Based Biomarkers: Cost-Effectiveness of Methylated Septin 9 DNA versus Current Strategies
Uri Ladabaum et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2013)
Colonoscopy screening markedly reduces the occurrence of colon carcinomas and carcinoma-related death: a closed cohort study
Christine N. Manser et al.
GASTROINTESTINAL ENDOSCOPY (2012)
Circulating Methylated SEPT9 DNA in Plasma Is a Biomarker for Colorectal Cancer
Theo deVos et al.
CLINICAL CHEMISTRY (2009)
DNA methylation biomarkers for blood-based colorectal cancer screening
Catherine Lofton-Day et al.
CLINICAL CHEMISTRY (2008)
Barriers to screening colonoscopy for low-income latino and white patients in an urban community health center
Alexander R. Green et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2008)
The pathobiology of the septin gene family
PA Hall et al.
JOURNAL OF PATHOLOGY (2004)
Cost-effectiveness of screening for colorectal cancer in the general population
AL Frazier et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Share Paper
